Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced that Kartik Ramamoorthi, Ph.D., Chief Executive ...

The eyes are often said to be a window to the soul. This study suggests they may offer a better view of the mind. In A ...

In a landscape where precision is paramount, the base editing market is emerging as a cornerstone of modern biotechnology, ...

Equity Insider News Commentary - The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The ...

A wife, husband and their now-adult child say the mistake happened 44 years ago, but they only found out in recent years.

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

An Ohio teenager died from complications of a bone marrow transplant after developing a "rare" genetic condition caused by ...

After years of looking at disguised prototypes and a lengthy teaser campaign, Toyota has finally revealed the GR GT supercar in both road-going and GT3 racer guises. Shown for the first time at an ...

Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...

A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.